Gebro Pharma (Spain)

Recent papers from Gebro Pharma (Spain)

1. Pricing Combination Therapies: A Systematic Review of Value Attribution, Cost-Sharing Mechanisms and Policy FrameworksApplied Health Economics and Health Policy · 2026
2. A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy TestingInternational Journal of Molecular Sciences · 2025
3. Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled TrialPain Practice · 2025
4. Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary CareGastroenterología y Hepatología (English Edition) · 2025
5. Methotrexate treatment strategies for rheumatoid arthritis: a scoping review on doses and administration routesBMC Rheumatology · 2024
6. Preclinical Studies with Glioblastoma Brain Organoid Co-Cultures Show Efficient 5-ALA Photodynamic TherapyCells · 2023
7. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritisReumatología Clínica (English Edition) · 2022
8. Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A ReviewDrug Healthcare and Patient Safety · 2021
9. Anti‐inflammatory effect of amygdalin analogs following topical administration on the TPA‐induced irritant contact dermatitis model in miceExperimental Dermatology · 2021
10. Usefulness of Peripheral Blood Monocyte Count to Predict Relapse in Patients With Inflammatory Bowel Disease: A Prospective Longitudinal Cohort Study.Revista Española de Enfermedades Digestivas · 2021
11. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritisReumatología Clínica · 2020
12. Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in SpainJournal of health economics and outcomes research · 2018
13. Rapid Improvement of Canine Cognitive Dysfunction with Immunotherapy designed for Alzheimer's DiseaseCurrent Alzheimer Research · 2013
14. Treatment of Scalp Psoriasis: Review of the Evidence and Delphi Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologyActas Dermo-Sifiliográficas · 2010